FACT SHEET FOR PROVIDERS LETTER OF AUTHORIZATION How can we help you? Report a side effect Online:Moderna'sAdverse Event Intake Portalor U.S. HHS'sVaccine Adverse Event Reporting System Connect with us Email:WeCare@modernatx.com Call:1-866-MODERNA (1-866-663-3762)Monday - Friday 8:00 AM...
The Moderna COVID-19 vaccine 2024-2025 Formula is an mRNA COVID-19 vaccine that may help your child develop immunity to SARS-CoV-2, the virus that causes COVID-19. The number of doses depends on age, vaccination status, and immune system status. The Moderna COVID-19 vaccine has ...
Moderna, Inc. announced that it has submitted a request to the U.S. Food and Drug Administration for an amendment to the emergency use authorization to allow for a fourth dose of its COVID-19 vaccine in adults 18 years of age and older ...
Similar to adults, Moderna is preparing to evaluate the potential of a booster dose for all pediatric populations, including those age 6 months to under 6 years, 6 to under 12 years, and adolescents. The Company is ...
financials. Stephen will provide the clinical update, especially new human data about two of our COVID-19 booster candidates, mRNA-1273, the currently authorized vaccine, and mRNA-1273.351, the variant-specific booster to B.1.351 first adopted by in South Africa. I will then come back to ...